Business Context and Reporting Period
Company: Rayonier Advanced Materials Inc. (RYAM)
Filing Type: Form 8-K (Current Report)
Date of Report: March 21, 2022
Event: Adoption of a Shareholder Rights Plan (Poison Pill) and declaration of a dividend of preferred share purchase rights.
Key Financial Metrics
This filing is a current report regarding a corporate governance action and does not contain financial performance data. The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Corporate Actions
- Shareholder Rights Plan: The Board adopted a rights plan in response to recent stock activity and the accumulation of a substantial amount of Company stock.
- Dividend Declaration: A dividend of one preferred share purchase right (a "Right") for each outstanding share of common stock was declared.
- Record and Payable Dates: The dividend is payable on March 31, 2022, to stockholders of record as of the close of business on that date.
- Trigger Thresholds: The plan imposes penalties on any person or group acquiring beneficial ownership of 10% or more of common stock (20% for certain passive institutional investors) without Board approval.
- Expiration: The Rights have a 364-day term and will expire on March 20, 2023, unless terminated earlier by the Board.
Terms of the Rights Agreement
- Exercise Price: $35.00 per Right to purchase one one-hundredth of a share of Series A Junior Participating Preferred Stock.
- Redemption: The Board may redeem the Rights for $0.01 per Right at any time before an "Acquiring Person" emerges.
- Flip-In Provision: If an Acquiring Person emerges, non-acquiring holders may purchase Company Common Stock with a market value of twice the Exercise Price.
- Flip-Over Provision: If the Company is acquired in a merger after the Rights become exercisable, holders may purchase shares of the acquiring corporation with a market value of twice the Exercise Price.
- Amendments: The Board may amend the agreement without shareholder consent prior to an acquisition event.
Investor Verification Checklist
- Verify the current beneficial ownership percentages of major shareholders to determine if any are near the 10% or 20% trigger thresholds.
- Review the full Rights Agreement (Exhibit 4.1) for specific definitions of "Acquiring Person" and derivative treatment.
- Monitor for any press releases or filings indicating the Board's intent to redeem the Rights prior to the March 20, 2023 expiration.
- Confirm the impact of the rights plan on potential merger or acquisition proposals.